SLDB Solid Biosciences Inc.: institutional ownership and insider trading
162 funds reported holding $1.19B of Solid Biosciences Inc. in their latest 13F filings; in Q2 2026 funds net bought $179M, with 43 new positions and 24 funds selling out; over the last 12 months insiders bought $0 and sold $2.69M on the open market.
Famous investors holding SLDB
- Ken Griffin (Citadel Advisors): $28.4M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $2.23M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $820K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $606K, 0.0% of the portfolio
Largest institutional holders of SLDB
- RA CAPITAL MANAGEMENT, L.P. — $120M
- PERCEPTIVE ADVISORS LLC — $119M
- Bain Capital Life Sciences Investors, LLC — $98.0M
- Siren, L.L.C. — $76.8M
- BlackRock, Inc. (BLK) — $69.3M
- FMR LLC — $68.7M
- ARMISTICE CAPITAL, LLC — $42.7M
- STATE STREET CORP (STT, STT-PG) — $41.7M
- Jupiter Topco LLC — $40.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $40.1M
Recent SLDB insider trades
- Oct 19, 2026: Brooks Gabriel sold 4,374 shares ($24.6K)
- Feb 18, 2026: Tan Kevin sold 5,404 shares ($31.5K)
- Feb 18, 2026: Brooks Gabriel sold 0 shares ($0)
- Feb 18, 2026: Howton David T sold 7,469 shares ($43.5K)
5%+ owners
- RA Capital Management, L.P.: 11.9% (Schedule 13D/A, filed Jun 24, 2026)
- Perceptive Advisors LLC: 11.2% (Schedule 13D/A, filed Aug 14, 2026)
- Raymond Debbane: 10.0% (Schedule 13G/A, filed May 5, 2026)
- FMR LLC: 7.0% (Schedule 13G, filed Aug 6, 2026)
- BlackRock, Inc.: 6.5% (Schedule 13G, filed Jul 30, 2026)